Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system

Biochemical Pharmacology

Volumn 56, Issue 9, 1998, Pages 1079-1087

  Haskó, György ^a   Szabó, Csaba ^b  

^a INOTEK CORPORATION   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

ATP; Epinephrine; Interleukin; Neurotransmission; Norepinephrine; Purinergic; Sympathetic nervous system; Tumor necrosis factor

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ADRENERGIC RECEPTOR; CHEMOKINE; CYTOKINE; FREE RADICAL; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUROTRANSMITTER; NITRIC OXIDE; NORADRENALIN; PURINE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

AUTONOMIC NERVOUS SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031741566     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00153-1     Document Type: Note

References (111)

1. Selye H, Thymus and adrenals in the response of the organism to injuries and intoxications. Br J Exp Pathol 17: 234-248, 1936.
2. Besedovsky HO, Sorkin E, Keller M and Müller J, Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 150: 466-470, 1975.
3. Hall RC and Hodge RL, Vasoactive hormones in endotoxin shock: A comparative study in cats and dogs. J Physiol (Lond) 213: 69-84, 1971.
4. Lundberg JM, Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48: 113-178, 1996.
5. White TD and MacDonald WF, Neural release of ATP and adenosine. Ann NY Acad Sci 603: 287-298, 1990.
6. Williams JM and Felten DL, Sympathetic innervation of murine thymus and spleen: A comparative histofluorescence study. Anat Rec 199: 531-542, 1981.
7. Bulloch K and Pomerantz W, Autonomic nervous system innervation of thymic-related lymphoid tissue in wildtype and nude mice. J Comp Neurol 228: 57-68, 1984.
8. Felten DL, Felten SY, Carlson SL, Olschowka JA and Livnat S, Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135: 755s-765s, 1985.
9. Vizi ES, Orsó E, Osipenko ON, Haskó G and Elenkov IJ, Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68: 1263-1276, 1995.
10. Kurz B, Feindt J, von Gaudecker B, Kranz A, Loppnow H and Mentlein R, β-Adrenoceptor-mediated effects in rat cultured thymic epithelial cells. Br J Pharmacol 120: 1401-1408, 1997.
11. Felten SY, Felten DL, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowka JA and Livnat S, Noradrenergic sympathetic innervation of lymphoid organs. Prog Allergy 43: 14-36, 1988.
12. Haskó G, Elenkov IJ and Vizi ES, Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus. Immunol Lett 47: 133-137, 1995.
13. Elenkov IJ and Vizi ES, Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology 30: 1319-1324, 1991.
14. Zhou ZZ, Wurster RD and Jones SB, Arterial baroreflexes are not essential in mediating sympathoadrenal activation in conscious endotoxic rats. J Auton Nerv Syst 39: 1-12, 1992.
15. Qi M, Zhou ZZ, Wurster RD and Jones SB, Mechanisms involved in the rapid dissipation of plasma epinephrine response to bacterial endotoxin in conscious rats. Am J Physiol 261: R1431-R1437, 1991.
16. Dunn AJ and Hall NRS, CNS biogenic amines and the immune system. In: The Physiology of Immunity (Eds. Marsh JA and Kendall MD), pp. 145-156. CRC Press, Boca Raton, FL, 1996.
17. Friedman EM and Irwin MR, Modulation of immune cell function by the autonomic nervous system. Pharmacol Ther 74: 27-38, 1997.
18. Besedovsky HO, del Rey AE and Sorkin E, Immune-neuroendocrine interactions. J Immunol 135 (Suppl 2): 750s-754s, 1985.
19. 2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265: C577-C606, 1993.
20. Jabs CM, Neglen P and Eklof B, Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxic shock. Eur J Surg 161: 147-155, 1995.
21. Bardenheuer H and Thiel M, The biological role of adenosine for the cellular function during sepsis. Prog Appl Microcirc 18: 112-131, 1991.
22. Schmidt H, Siems WG, Grune T and Grauel EL, Concentration of purine compounds in the cerebrospinal fluid of infants suffering from sepsis, convulsions and hydrocephalus. J Perinat Med 23: 167-174, 1995.
23. Schmidt H, Weigand MA, Li C, Schmidt W, Martin E and Bardenheuer HJ, Intestinal formation of hypoxanthine and uric acid during endotoxemia. J Surg Res 71: 61-66, 1997.
24. Grum CM, Simon RH, Dantzker DR and Fox IH, Evidence for adenosine triphosphate degradation in critically-ill patients. Chest 88: 763-767, 1985.
25. Besedovsky HO, del Rey A, Sorkin E and Dinarello C, Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233: 652-654, 1986.
26. Besedovsky HO and del Rey A, Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 17: 64-102, 1996.
27. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS and Biron CA, Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J Exp Med 181: 901-914, 1995.
28. Davatelis G, Wolpe SD, Sherry B, Dayer JM, Chicheportiche R and Cerami A, Macrophage inflammatory protein-1: A prostaglandin-independent endogenous pyrogen. Science 243: 1066-1068, 1989.
29. Chrousos GP, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351-1362, 1995.
30. Wilder RL, Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13: 307-338, 1995.
31. Sternberg EM, Neural-immune interactions in health and disease. J Clin Invest 100: 2641-2647, 1997.
32. Madden KS, Sanders VM and Felten DL, Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35: 417-448, 1995.
33. Fuchs BA, McCall CO and Munson AE, Enhancement of the murine primary antibody response by phenylephrine in vitro. Drug Chem Toxicol 14: 67-82, 1991.
34. 1-adrenergic receptors by radioligand binding analysis. J Allergy Clin Immunol 74: 812-818, 1984.
35. van der Poll T, Jansen J, Endert E, Sauerwein HP and van Deventer SJH, Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62: 2046-2050, 1994.
36. van der Poll T, Coyle SM, Barbosa K, Braxton CC and Lowry SF, Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97: 713-719, 1996.
37. Heijnen CJ, van de Voort CR, Wulffraat N, van der Net J, Kuis W and Kavelaars A, Functional αl-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol 71: 223-226, 1996.
38. Spengler RN, Allen RM, Remick DG, Strieter RM and Kunkel SL, Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145: 1430-1434, 1990.
39. Spengler RN, Chensue SW, Giacherio DA, Blenk N and Kunkel SL, Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J Immunol 152: 3024-3031, 1994.
40. Bertini R, Garattini S, Delgado R and Ghezzi P, Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology 79: 217-219, 1993.
41. 2-adrenoceptors on plasma levels of tumour necrosis factor-α, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J Endocrinol 144: 457-462, 1995.
42. Elenkov IJ, Haskó G, Kovács KJ and Vizi ES, Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J Neuroimmunol 61: 123-131, 1995.
43. Fessler HE, Otterbein L, Chung HS and Choi AMK, Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide. Am J Respir Crit Care Med 154: 1689-1693, 1996.
44. 2-adrenoreceptor blockade on IL-10, IL-12 and MIP-1α production in endotoxemia. Shock, 9 (Suppl 1): 32, 1998.
45. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr and Trendelenburg U, IV. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121-136, 1994.
46. Haskó G, Szabó C, Németh ZH, Salzman AL and Vizi ES, Suppression of interleukin-12 production by phosphodiesterase inhibition in murine endotoxemia is interleukin-10 independent. Eur J Immunol 28: 468-472, 1998.
47. Németh ZH, Haskó G, Szabó C and Vizi ES, Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock 7: 371-375, 1997.
48. Németh ZH, Szabó C, Haskó G, Salzman AL and Vizi ES, Effect of the PDE III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774-1 macrophages. Eur J Pharmacol 339: 215-221, 1997.
49. van der Pouw Kraan TCTM, Boeije LCM, Smeenk RJT, Wijdenes J and Aarden LA, Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775-779, 1995.
50. Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M and Strassmann G, Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J Immunol 155: 4909-4916, 1995.
51. Szabó C, Haskó G, Németh ZH and Vizi ES, Calcium entry blockers increase interleukin-10 production in endotoxemia. Shock 7: 304-307, 1997.
52. Németh ZH, Haskó G, Szabó C, Salzman AL and Vizi ES, Calcium channel blockers and dantrolene differentially regulate the production of interleukin-12 and interferon-γ in endotoxemic mice. Brain Res Bull, 46: 257-261, 1998.
53. Haskó G, Németh Z, Vizi ES and Szabó C, Anti-inflammatory profile of dantrolene: Inhibition of endotoxin-induced tumor necrosis factor and enhancement of interleukin-10 production, but no effect on nitric oxide and interleukin-6 production. Shock 5: S45, 1996.
54. Hu X, Goldmuntz EA and Brosnan CF, The effect of norepinephrine on endotoxin-mediated macrophage activation. J Neuroimmunol 31: 35-42, 1991.
55. Severn A, Rapson NT, Hunter CA and Liew FY, Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 148: 3441-3445, 1992.
56. Ignatowski TA and Spengler N, Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J Neuroimmunol 61: 61-70, 1995.
57. Haskó G, Németh ZH, Szabó C, Zsilla G, Salzman AL and Vizi ES, Isoproterenol inhibits IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages. Brain Res Bull 45: 183-187, 1998.
58. Liao J, Keiser JA, Scales WE, Kunkel SL and Kluger MJ, Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 268: R896-R901, 1995.
59. Linden A, Increased interleukin-8 release by β-adrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol 119: 402-406, 1996.
60. 2-Adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol 77: 211-216, 1997.
61. van der Poll T and Lowry SF, Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect Immun 65: 2378-2381, 1997.
62. Haskó G, Nemeth Z, Vizi ES, Salzman AL and Szabó C, Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 and MIP-1α production in mice. Shock, 9 (Suppl 1): 28-29, 1998.
63. 2-Agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100: 1513-1519, 1997.
64. Elenkov IJ, Papanicolau DA, Wilder RL and Chrousos GP, Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc Assoc Am Physicians 108: 1-8, 1996.
65. Ramer-Quinn DS, Baker RA and Sanders VM, Activated T helper 1 and T helper 2 cells differentially express the β-2-adrenergic receptor: A mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol 159: 4857-4867, 1997.
66. 2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. J Immunol 158: 4200-4210, 1997.
67. Szabó C, Haskó G, Zingarelli B, Németh ZH, Salzman AL, Kvetan V, Pastores SM and Vizi ES, Isoproterenol regulates TNF, IL-10, IL-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxemia. Immunology 90: 95-100, 1997.
68. Monastra G and Secchi EF, β-Adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. Immunol Lett 38: 127-130, 1993.
69. Sekut L, Champion BR, Page K, Menius JA Jr and Connolly KM, Anti-inflammatory activity of salmeterol: Down-regulation of cytokine production. Clin Exp Immunol 99: 461-466, 1995.
70. Suberville S, Bellocq A, Fouqueray B, Philippe C, Lantz O, Perez J and Baud L, Regulation of interleukin-10 production by β-adrenergic agonists. Eur J Immunol 26: 2601-2605, 1996.
71. Le Tulzo Y, Shenkar R, Kaneko D, Moine P, Fantuzzi G, Dinarello CA and Abraham E, Hemorrhage increases cytokine expression in lung mononuclear cells in mice. J Clin Invest 99: 1516-1524, 1997.
72. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, Grünig G and Rennick D, Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96: 2339-2347, 1995.
73. Haskó G, Szabó C, Németh Z, Salzman AL and Vizi ES, Stimulation of β-adrenoceptors inhibits endotoxin-induced IL-12 production in mice. J Neuroimmunol, 88: 57-61, 1998.
74. Di Virgilio F, The P2Z purinoreceptor: An intriguing role in immunity, inflammation and cell death. Immunol Today 16: 524-528, 1995.
75. Di Virgilio F, Ferrari D, Chiozzi P, Falzoni S, Sanz JM, dal Susino M, Mutini C, Hanau S and Baricordi OR, Purinoreceptor function in immune system. Drug Dev Res 39: 319-329, 1996.
76. Cronstein BN, Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76: 5-13, 1994.
77. Salmon JE, Brogle N, Brownlie C, Edberg JC, Kimberly RP, Chen BN and Erlanger BF, Human mononuclear phagocytes express adenosine A1 receptors. J Immunol 151: 2775-2785, 1993.
78. Eppel BA, Newell AM and Brown EJ, Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. J Immunol 143: 4141-4145, 1989.
79. 3 receptors on macrophages inhibits tumor necrosis factor-α. Eur J Pharmacol 310: 209-216, 1996.
80. Hogquist KA, Nett MA, Unanue ER and Chaplin DD, Interleukin-1 is processed and released during apoptosis. Proc Natl Acad Sci USA 88: 8485-8489, 1991.
81. Griffiths RJ, Stam EJ, Downs JT and Otterness IG, ATP induces the release of IL-1 from LPS-primed cells in vivo. J Immunol 154: 2821-2828, 1995.
82. Ferrari D, Chiozzi P, Falzoni S, Hanau S and Di Virgilio F, Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185: 579-582, 1997.
83. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR and Di Virgilio F, Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159: 1451-1458, 1997.
84. Proctor RA, Denlinger LC, Leventhal PS, Daugherty SK, van de Loo J-W, Tanke T, Firestein GS and Bertics PJ, Protection of mice from endotoxic death by 2-methylthio-ATP. Proc Natl Acad Sci USA 91: 6017-6020, 1994.
85. Denlinger LC, Fisette PL, Garis KA, Kwon G, Vazquez-Torres A, Simon AD, Nguyen B, Proctor RA, Bertics PJ and Corbett JA, Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 271: 337-342, 1996.
86. Parmely MJ, Zhou WW, Edwards CK III, Borcherding DR, Silverstein R and Morrison DC, Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-a production and protect mice against endotoxin challenge. J Immunol 151: 389-396, 1993.
87. Bouma MG, Stad RK, van den Wildenberg FAJM and Buurman WA, Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153: 4159-4168, 1994.
88. 2 receptors on rat Kupffer cells. Hepatology 19: 1445-1452, 1994.
89. 2A receptors. Trends Pharmacol Sci 17: 364-372, 1996.
90. Le Vraux V, Chen YL, Masson I, De Sousa M, Giroud JP, Florentin I and Chauvelot-Moachon L, Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 52: 1917-1924, 1993.
91. Haskó G, Szabó C, Németh ZH, Kvetan V, Pastores SM and Vizi ES, Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 157: 4634-4640, 1996.
92. Le Moine O, Stordeur P, Schandené L, Marchant A, de Groote D, Goldman M and Deviere J, Adenosine enhances IL-10 secretion by human monocytes. J Immunol 156: 4408-4414, 1996.
93. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC and Firestein GS, Inhibition of TNF-α expression by adenosine. Role of A3 adenosine receptors. J Immunol 156: 3435-3442, 1996.
94. 3 adenosine receptors decreases IL-12, IFN-γ, and nitric oxide production and prevents lethality in endotoxemic mice. Naunyn Schmiedebergs Arch Pharmacol 356: R45, 1997.
95. Shanley TP, Haskó G, Egnaczyk G, Salzman AL and Szabó C, Suppression of macrophage inflammatory protein (MIP)-1 alpha production by adenosine receptor agonists in immunostimulated macrophages. FASEB J 12: A766, 1998.
96. Pastores SM, Haskó G, Vizi ES and Kvetan V, Cytokine production and its manipulation by vasoactive drugs. New Horiz 4: 252-264, 1996.
97. Chernow B and Roth BL, Pharmacologic manipulation of the peripheral vasculature in shock: Clinical and experimental approaches. Circ Shock 18: 141-155, 1986.
98. Bond RF and Johnson G 3d, Vascular adrenergic interactions during hemorrhagic shock. Fedn Proc 44: 281-289, 1985.
99. Wiegmann K, Muthyala S, Kim DH, Arnason BGW and Chelmicka-Schorr E, β-Adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol 56: 201-206, 1995.
100. Goldmuntz EA, Brosnan CF and Norton WT, Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol 137: 3444-3450, 1986.
101. 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats. J Neuroimmunol 51: 177-183, 1994.
102. 2-adrenergic agonist terbutaline suppresses acute passive transfer of experimental autoimmune myasthenia gravis (EAMG). Int J Immunopharmacol 15: 19-24, 1993.
103. Felten DL, Felten SY, Bellinger DL and Lorton D, Noradrenergic and peptidergic innervation of secondary lymphoid organs: Role in experimental rheumatoid arthritis. Eur J Clin Invest 22 (Suppl 1): 37-41, 1992.
104. Kaplan R, Robinson CA, Scavulli JF and Vaughan JH, Propranolol and the treatment of rheumatoid arthritis. Arthritis Rheum 23: 253-255, 1980.
105. 2-Adrenergic mechanisms in experimental arthritis. Proc Natl Acad Sci USA 85: 4553-4556, 1988.
106. 2-adrenoceptors. Neuroscience 34: 521-523, 1990.
107. 2-adrenoceptors to suppress experimental arthritis. Brain Res 544: 325-328, 1991.
108. Green PG, Basbaum AI, Helms C and Levine JD, Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat. Proc Natl Acad Sci USA 88: 4162-4165, 1991.
109. Szabó C, Haskó G, Scott GS, Virág L, Egnaczyk G and Salzman AL, Adenosine 3 receptor stimulation exerts potent anti-inflammatory effects in vivo. FASEB J 12: A243, 1998.
110. Cronstein BN, Van de Stouwe M, Druska L, Levin RI and Weissmann G, Nonsteroidal anti inflammatory agents inhibit stimulated neutrophil adhesion to endothelium: Adenosine dependent and independent mechanisms. Inflammation 18: 323-325, 1994.
111. Cronstein BN, Eberle MA, Gruber HE and Levin RI, Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 88: 2441-2445, 1991.